Peter E. Haas Jr. Family Fund

Peter E. Haas Jr. Family Fund sells 145,662 LEVI shares at $24.01; stock up 35.3% in 90 days via 10b5-1 plan

Peter E. Haas Jr. Family Fund executed a scheduled sale of 145,662 shares at $24.01 on 2026-06-11 under a pre-arranged 10b5-1 trading plan adopted on 2026-04-13, reducing non-derivative holdings to zero while retaining Class B Common Stock derivative holdings of 23,628,400 shares. The sale occurred after the stock appreciated 35.3% over 90 days and 12.4% over 30 days, yet the insider's cross-ticker historical pattern shows an average 90-day return of -16.0% following prior sales across multiple stocks. At LEVI specifically, the insider's four prior sales have produced mixed outcomes: the most recent 2025-10-01 sale saw the stock decline -12.8% in 90 days, while earlier 2024 sales yielded similar negative 90-day returns ranging from -14.4% to -18.5%, despite modest 30-day gains. The timing-independent nature of the 10b5-1 plan removes any discretionary signal from this transaction, making it a mechanical execution rather than a conviction-driven decision.

Peter E. Haas Jr. Family Fund sells 150,000 LEVI shares at $24.19; cross-ticker history shows 100% well-timed 90d timing on prior sells.

The Haas family fund sold 150,000 shares of Levi Strauss on October 1, 2025, at $24.19, near the current 52-week high of $24.45. Notably, this sale occurs after a sharp 30-day gain of +8.6% and a 90-day rise of +27.9%, positioning the stock at an elevated level relative to the past year. The fund's cross-ticker track record is notable: across 3 prior open-market sells at other tickers, the insider achieved a 100.00% well-timed rate at the 90-day mark—meaning prior sales were consistently followed by stock declines. At Levi Strauss specifically, all 3 prior sales (in May 2024) were similarly well-timed, with negative 90-day returns of -14.4%, -18.5%, and -18.3% following each. This consistent pattern of sales preceding subsequent downturns warrants investor attention, though the company's valuation metrics show a notably elevated P/E of 46.13 against net income of $67,000,000.